IMPAX Laboratories, Inc. Reports Third Quarter 2013 Results

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Impax Laboratories, Inc. (NASDAQ: IPXL) today reported third quarter 2013 adjusted net income of $16.6 million, or $0.25 per diluted share, compared to adjusted net income of $33.0 million, or $0.48 per diluted share in the prior year period. On a GAAP basis, the Company recorded a net loss of $0.2 million or ($0.00) per diluted share for the third quarter 2013, compared to net income of $20.0 million, or $0.29 per diluted share in the prior year period.

Help employers find you! Check out all the jobs and post your resume.

Back to news